Table 2.
Treatment Profiles for Patients with PTSD in Integrated Health Care Systems
| Parameter | Mental Health Care |
Primary/Other Care |
Total | Chi- square |
|||
|---|---|---|---|---|---|---|---|
| Type of Treatment | n | % | n | % | N | % | p-value |
| All Psychotherapy sessions | 3,476 | 79.3 | 213 | 24.4 | 3,689 | 70.2 | <.0001 |
| All Psychotherapy Sessions with PTSD Diagnosis | 2,946 | 67.2 | 71 | 8.1 | 3,017 | 57.4 | <.0001 |
| Psychotherapy Sessions in Mental Health Clinics | 3,278 | 74.8 | 119 | 13.6 | 3,397 | 64.6 | <.0001 |
| Psychotherapy Sessions in Mental Health Clinics with PTSD Diagnosis | 2,797 | 63.8 | 0 | 0 | 2,797 | 53.2 | <.0001 |
| Psychotherapy Sessions from Non-mental Health Providers1 | 770 | 17.6 | 119 | 13.6 | 889 | 16.9 | 0.005 |
| Psychotherapy Sessions from Non-mental Health Providers with PTSD Diagnosis | 441 | 10.1 | 71 | 8.1 | 512 | 9.7 | 0.080 |
| SSRI/SNRI | 2,435 | 55.6 | 310 | 35.5 | 2,745 | 52.2 | <.0001 |
| Other Antidepressant | 1,632 | 37.2 | 191 | 21.9 | 1,823 | 34.7 | <.0001 |
| Sedatives Excluding Benzodiazepines | 865 | 19.7 | 102 | 11.7 | 967 | 18.4 | <.0001 |
| Benzodiazepines | 993 | 22.7 | 122 | 14.0 | 1,115 | 21.2 | <.0001 |
| Prazosin | 342 | 7.8 | 26 | 3.0 | 368 | 7.0 | <.0001 |
| Antipsychotics | |||||||
| Typical | 35 | 0.8 | 3 | 0.3 | 38 | 0.7 | 0.10 |
| Atypical | 957 | 21.8 | 71 | 8.1 | 1,028 | 19.6 | <.0001 |
Note.
1
Non-mental health providers included licensed/credentialed providers in the health system, only. These do not include community health workers or peer specialists.